Min.Order / FOB Price:Get Latest Price
1 Gram |
FOB Price: USD 15.0000 |
Peptides Pharmaceutical Intermediate Chemical
This is Allen from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.
Our Company as a Pharmaceutical Raw Material Manufacturer specialize in R&D the New Drugs and Producing the Generic Medicine:
Amino Acids&Vitamins
Pharmaceutical Polypeptide,
Comestic Polypeptide,
Veterinary Peptide and
Pharmaceutical APIs.
Due to of the high quality and good service, They have been exported more than 30 countries.
Sincerely hope to have a chance to cooperate with you
Description
GHRP-2
Usage:Ghrelin not only to promote the release of growth,
but also has other biological effects, such as mediation feeding and energy metabolism, cardiovascular
function, control gastrointestinal function and inhibition of tumor cell proliferation and so on .
Recent studies have shown that serum ghrelin concentration was positively correlated with BMD,
so ghrelin may be involved in the metabolism of bone tissue, affecting the function of osteoblasts
GHRP2 is a synthetic ghrelin analogue. Like ghrelin, it stimulates release of endogenous from
somatotropes in the anterior pituitary; also like ghrelin, it is synergistic with endogenous releasing-ormone (GHRH) as well as with synthetic GHRH analogues such as Sermorelin or GRF(1-29).
Whereas GHRP2 and other ghrelin analogues increase the number of somatotropes involved in
the GH pulse by inhibiting somatostatin, GHRH increases the pulse amplitude per pituitary cell
or somatotrope by other means. Unlike ghrelin, GHRP2 is not lipogenic meaning it does not induce
fat storage. While ghrelin has a very important role in hunger, GHRP2 as an analog of ghrelin does
not increase appetite significantly. GHRP2 is synergistic with GHRH due to secondary actions on
hypothalamic neurons. The quantity of GH released by a living mammal to which GHRP2 and GHRH
are administered exceeds the combined release of each compound when measured when taken
alone.
CAS NO:33515-09-2
CAS NO:33515-09-2
CAS NO:307297-39-8
CAS NO:141732-76-5
CAS NO:56-59-7
CAS NO:129954-34-3
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View